Amphastar PharmaceuticalsvsMerck & Company

AMPH and MRK stock compared: price, dividend, valuation and results, from SEC filings.

AMPH

Amphastar Pharmaceuticals, Inc.

$29.37

Value $1.3B

+1.73%
AMPH's page

MRK

Merck & Company, Inc.

$147.76

Value $365B

+0.55%
MRK's page

Amphastar Pharmaceuticals (AMPH) has a market value of $1.3B and Merck & Company (MRK) $365B. Over the last year, with dividends, AMPH moved +5.5% and MRK +66.3%. The P/E is 12.7 for AMPH and 148.9 for MRK. Dividend yield: AMPH none, MRK 2.30%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMPH$1.3B

    MRK$365B

    MRK is 292 times AMPH

  • Revenue, 12 months

    AMPH$746M

    MRK$67.4B

    MRK is 90 times AMPH

  • Net income, 12 months

    AMPH$99M

    MRK$2.5B

    MRK is 25 times AMPH

  • Operating margin

    AMPH18.7%

    MRK–

  • ROIC

    AMPH7.6%

    MRK3.9%

    3.8 points apart

  • P/E

    AMPH12.7

    MRK148.9

    MRK is 12 times AMPH

  • Dividend yield

    AMPH0.0%

    MRK2.3%

    2.3 points apart

  • 5-year return

    AMPH+37.9%

    MRK+104.9%

    67.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMPH+37.9%

MRK+104.9%

10020030020222023202420252026
Returns by period
PeriodAMPHWith dividendsMRKWith dividends
1 year since November 12, 2025+5.5%Price +5.5%+66.3%Price +61.6%
3 years since November 13, 2023-45.2%-18.1% a yearPrice -45.2%+58.0%+16.5% a yearPrice +44.2%
5 years since November 12, 2021+37.9%+6.6% a yearPrice +37.9%+104.9%+15.4% a yearPrice +75.9%
10 years since November 15, 2016+39.8%+3.4% a yearPrice +39.8%+230.1%+12.7% a yearPrice +143.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMPHAmphastar PharmaceuticalsMRKMerck & Company

Valuation

AMPHMRK
Valuation
Price$29.37$147.76
Market value$1.3B$365B
Enterprise value (EV)$1.6B$409B
P/E12.7148.9
P/E, 5-year median16.114.8
P/B1.58.1
EV/EBIT11.786.0
Free cash flow yield11.1%4.0%

Results and growth

AMPHMRK
Results and growth
Revenue, 12 months$746M$67.4B
Net income, 12 months$99M$2.5B
Free cash flow, 12 months$139M$14.7B
Earnings per share, 12 months$2.19$0.98
Revenue growth, year on year-1.7%1.3%
Revenue growth a year, past+15.5%over 5 years+9.4%over 5 years
EPS growth a year, past+132.3%over 5 years+21.2%over 5 years

Margins and returns on capital

AMPHMRK
Margins and returns on capital
Gross margin46.8%71.8%
Operating margin18.7%–
Net margin13.3%3.6%
ROIC7.6%3.9%
ROE12.6%5.2%

Balance sheet

AMPHMRK
Balance sheet
Cash$231M$9.7B
Total debt$692M$53.8B
Net debt / EBITDA2.25.7
Interest cover5.3×2.4×

Dividends and buybacks

AMPHMRK
Dividends and buybacks
Dividend yield–2.3%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield6.0%1.4%
Shareholder yield6.0%3.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMPH or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Amphastar Pharmaceuticals or Merck & Company?

By market value, Merck & Company ($365B) is about 291.6 times Amphastar Pharmaceuticals ($1.3B), at today's prices.

How did AMPH and MRK stock do over the last 10 years?

Since November 15, 2016, AMPH's price moved +39.8% and MRK's +143.3%. With dividends: AMPH +39.8% (+3.4% a year), MRK +230.1% (+12.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMPH or MRK?

The dividend yield at today's price is none for Amphastar Pharmaceuticals and 2.30% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of AMPH and MRK?

At today's price, the P/E is 12.7 for AMPH and 148.9 for MRK. The median of the last five years was 16.1 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Amphastar Pharmaceuticals or Merck & Company?

Over the last twelve months, the net margin was 13.3% for Amphastar Pharmaceuticals and 3.6% for Merck & Company, and the operating margin 18.7% and –. Revenue was $746M and $67.4B.

Which is the better investment, Amphastar Pharmaceuticals or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.